Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centrosomal protein of 41 kDa (CEP41) is a centrosome- and cilia-associated protein that plays a critical role in regulating tubulin glutamylation, a key post-translational modification essential for proper ciliary structure and function. CEP41 is necessary for the transport of TTLL6, a polyglutamylase enzyme, into the cilium and thus is required for ciliary tubulin glutamylation, but not for the initial assembly of the cilium itself. Loss or depletion of CEP41 leads to structural and functional cilia defects, impaired mechanotransduction in endothelial cells, deficient angiogenesis (via defective response to mechanical cues and hypoxic signals), and prominent features of ciliopathies such as Joubert syndrome, characterized by neurodevelopmental, renal, and retinal abnormalities as well as vascular defects. There are no currently known drugs directly targeting CEP41, and it is not a canonical drug target such as a receptor or enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centrosomal protein of 41 kDa (CEP41).